Oxacyclotetratetraconta-5,7,9,11,13,19,23,35-octaene-2,28-dione,44-[(1E,4R,5E,8R)-11-amino-4,8-dihydroxy-1,5-undecadien-1-yl]-23-(3-buten-1-yl)-26-[(6-deoxy-a-L-mannopyranosyl)oxy]-16,18,30,32,34,38,40,42-octahydroxy-15,17,27-trimethyl-,(5E,7E,9E,11E,13E,16S,17S,18R,19E,23E,32S,34S,35E,38R,40S,42R,44S)-,12710-02-0 Products Supply

Name: Oxacyclotetratetraconta-5,7,9,11,13,19,23,35-octaene-2,28-dione,44-[(1E,4R,5E,8R)-11-amino-4,8-dihydroxy-1,5-undecadien-1-yl]-23-(3-buten-1-yl)-26-[(6-deoxy-a-L-mannopyranosyl)oxy]-16,18,30,32,34,38,40,42-octahydroxy-15,17,27-trimethyl-,(5E,7E,9E,11E,13E,16S,17S,18R,19E,23E,32S,34S,35E,38R,40S,42R,44S)-
CAS NO.: 12710-02-0
Synonyms:
Lienomycin;Oxacyclotetratetraconta-5,7,9,11,13,19,23,35-octaene-2,28-dione,44-[(1E,4R,5E,8R)-11-amino-4,8-dihydroxy-1,5-undecadienyl]-23-(3-butenyl)-26-[(6-deoxy-a-L-mannopyranosyl)oxy]-16,18,30,32,34,38,40,42-octahydroxy-15,17,27-trimethyl-,(5E,7E,9E,11E,13E,16S,17S,18R,19E,23E,32S,34S,35E,38R,40S,42R,44S)- (9CI);Oxacyclotetratetracontane, lienomycin deriv.; Stereoisomer of44-(11-amino-4,8-dihydroxy-1,5-undecadienyl)-23-(3-butenyl)-26-[(6-deoxy-a-L-mannopyranosyl)oxy]-16,18,30,32,34,38,40,42-octahydroxy-15,17,27-trimethyloxacyclotetratetraconta-5,7,9,11,13,19,23,35-octaene-2,28-dione
Molecular Structure:
Molecular Formula: C67H107 N O18

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: Oxacyclotetratetraconta-5,7,9,; 1/C51H74N2/c1-5-9-13-17-21-49(; 1/C28H41N5O15S.Na/c1-12(2)21(2; 1/C33H42O7/c1-19-25-17-24-18-2; 1/C27H27N3O3S/c1-30-25(20-11-1; 1/C26H18O2/c1-17-16-23-21-9-5-; 1/C22H28O6/c1-23-17-11-21(27-5; 1/C21H26N2O4/c1-3-14-8-9-19(25; 1/C30H52/c1-10-25(6)16-12-20-3; 11',29'-di-tert-butyl-5',17',2; 1/C17H22N6/c1-2-8-19-13-11-14(; 1/C19H15ClN2O2S/c1-11-19(23)24; 1/C18H19NO4/c1-22-15-8-11-10(7; 1-[(1E,3E,5E,7E,9E,11E,13E,15E; 1/C16H15FN2O3S/c1-23(21,22)19-; 2-Cyclohexen-1-one,6-hydroxy-2; 1/C23H22N2O2/c26-23(27-22-15-2; 1/C19H24N2O2/c1-12(2)14-8-6-9-; 1/C18H18O6/c1-22-14-8-13(20)15; Spiro[furan-2(3H),2'-[2H,21H]p; Oxacyclodotriaconta-3,5,7,9,11; 1/C19H20O5/c1-11(2)7-18(21)24-; 2-Cyclohexen-1-one,3-[(1E,3E,5; Oxacyclooctadeca-3,5,13,15-tet; 1/C12H10N4O3/c1-3-19-12(18)10-; 3,5,7,9,11,13,15-Octadecahepta; 1/C11H14N2O6/c1-17-7(14)4-12-2; (5E)-5-[(3aS,4R,5R,6aS)-4-[(1E; 3-Cyclohexen-1-ol,4,4'-[(1E,3E; L-Ribonamide,N-[(3S)-3-[4-[(1E;